Tirzepatide
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
Eli Lilly · Phase 2 · Completed · Enrollment 354
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Dosing scheme a: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme a: Placebo | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme b: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme b: Placebo | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme c: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme c: Placebo | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme d: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme d: Placebo | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme e: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme e: Placebo | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme f: NNC0519-0130 | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme f: Placebo | n/r | n/r | n/r | n/r | n/r |
| Dosing scheme g: Tirzepatide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.